Figure 4 | Scientific Reports

Figure 4

From: Monitoring trifluridine incorporation in the peripheral blood mononuclear cells of colorectal cancer patients under trifluridine/tipiracil medication

Figure 4

FTD incorporation into PBMCs of mCRC patients who received TFTD medication. (a) The schedule of TFTD medication and blood sampling (upper). The first cycle was from day 1 to day 28, and the second cycle was from day 29 to day 56. (b–d) The fluctuation of the % FTD-positive PBMCs in each mCRC patient. The schedule of TFTD medication is indicated by line bar under the graph.

Back to article page